Managing cardiovascular risk with SphygmoCor XCEL

Similar documents
Managing anti-hypertensive treatment with SphygmoCor XCEL

Central Pressures and Prehypertension

APPLICATION OF PHYSICAL METHODS FOR DETERMINATION OF FUNCTIONAL PARAMETERS OF ARTERIES IN RHEUMATIC PATIENTS

boso ABI-system 100 inexpensive New feature: PWV Early detection of PAOD: fast, accurate The easy way of checking for measurement option

Clinical application of Arterial stiffness. pulse wave analysis pulse wave velocity

boso Germany reliably boso Abi-system 100 Premium quality seen in time Arteriosclerosis and economically. PWV measurement option.

boso Germany PAOD! The crucial Premium-quality risk marker for heart attack and stroke! Now PAOD screening with the boso ABI-system!

Departments of Cardiology and Vascular Surgery Michaelidion Cardiac Center University of Ioannina, Greece

Measurement of Arterial Stiffness: Why should I measure both PWA and PWV?

Theoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D.

Welch Allyn ABPM 6100S. Comprehensive blood pressure monitoring that brings patient comfort home.

Estimated Pulse Wave Velocity Calculated from Age and Mean Arterial Blood Pressure

Introduction of diverse devices to measure arterial stiffness

D Terentes-Printzios, C Vlachopoulos, G Vyssoulis, N Ioakeimidis, P Xaplanteris, K Aznaouridis, E Christoforatou, A Samentzas, A Siama, C Stefanadis

A NOVEL CARDIOVASCULAR RISK BIOMETRIC - AORTIC PULSE WAVE VELOCITY

LD TECHNOLOGY PRODUCT CATALOG

Endothelial function is impaired in women who had pre-eclampsia

Πρώιμη αγγειακή γήρανση στην υπέρταση: διάγνωση και αντιμετώπιση

/tj7-0zq0 510 (k) Summary P

INTERNATIONAL REGISTRY FOR AMBULATORY BLOOD PRESSURE AND ARTERIAL STIFFNESS TELEMONITORING

boso ABI-system 100 Early detection of PAOD fast, precise, without Doppler Premium quality for doctors and hospitals

LD TECHNOLOGY PRODUCT CATALOG

Pharmacological modulation of vascular structure and function. L. Van Bortel. Heymans Institute of Pharmacology, Ghent University

Which method is better to measure arterial stiffness; augmentation index, pulse wave velocity, carotid distensibility? 전북의대내과 김원호

Nomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure

Peripheral Vessels Unit, 1st Department of Cardiology Athens Medical School Hippokration Hospital, Athens, Greece

ARTERIAL STIFFNESS ASSESSMENT COMMENTS:

TODAY S TOPIC Blood Pressure & Pulse Wave Measurement Combined in One Procedure Re-classification of Risk Patients

Pulse wave velocity, augmentation index and arterial age in students

A Comparative Study of Methods of Measurement of Peripheral Pulse Waveform

The arterial system has a dual function:

VITAL SIGNS MONITORING. RVS-100/200 ri-vital. Vital Signs Patient Monitors

Effects of Renin-Angiotensin System blockade on arterial stiffness and function. Gérard M. LONDON Manhès Hospital Paris, France

Business Update. May Duncan Ross CEO Peter Manley CFO

EARLY DETECTION OF DIABETES COMPLICATIONS AUTONOMIC NERVOUS SYSTEM AND VASCULAR FUNCTION ASSESSMENTS

Automated Blood Pressure Monitor

Retinal vessel analysis in dyslipidemia: The eye, a window to the body s microcirculation

Central pressures and prediction of cardiovascular events in erectile dysfunction patients

vasolab 320 Vascular Diagnosis Center

Fibrinogen does not relate to cardiovascular or muscle manifestations in chronic

EVALUATION OF NONINVASIVE PULSE TRANSIT TIME METHODOLOGIES FOR DIAGNOSIS OF HYPERTENSION DANIEL JOHN BADGER. A thesis submitted to the

Arterial Age and Shift Work

Special Lecture 10/28/2012

Arterial stiffness index: A new evaluation for arterial stiffness in elderly patients with essential hypertension

Coronary artery disease (CAD) risk factors

Advances in Peritoneal Dialysis, Vol. 34, 2018

Effective methods in hypertension management

Comparison of the Assessment of Orthostatic Hypotension Using Peripheral and Central Blood Pressure Measurements

Determination of age-related increases in large artery stiffness by digital pulse contour analysis

Fitting System Instructions for Use

Name of Policy: Computerized Pulse Waveform Analysis

Interested parties (organisations or individuals) that commented on the draft document as released for consultation.

BC380. The New Standard in Body Composition Analysis BODY COMPOSITION ANALYZER

SOMNOcheck micro CARDIO. Simple Assessment of Cardiovascular Risk During Sleep. In sleep medicine In internal medicine In preventive medicine

A GUIDE TO OUR NIBP TECHNOLOGY

John Feely deceased. Received 21 October 2008 Revised 5 June 2009 Accepted 28 June 2009

ASSOCIATION OF SYSTEMIC INFLAMMATION WITH ARTERIAL STIFFNESS IN HYPERTENSION

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital

Operation Manual for Audiometer

Sleep diagnostics systems

ECG MACHINE KEC- Series

week by week in the Training Calendar. Follow up graphics, sort, filter, merge, and split functions are also included.

Progression of Central Pulse Pressure Over 1 Decade of Aging and its Reversal by Nitroglycerin

ARTERIAL STIFFNESS AND CORONARY ARTERY DISEASE

Device Equivalence Evaluation Form

QPV Interval as a Measure of Arterial Stiffness in Women with Systemic Lupus Erythematosus

Arterial Pressure in CKD5 - ESRD Population Gérard M. London

TWO CHANNEL CLINICAL AUDIOMETER AUDIOSTAR PRO

Arterial stiffness and central BP as goals for antihypertensive therapy in pre- and elderly. Piotr Jankowski

When should you treat blood pressure in the young?

For Professionals. SYNCHRONY System. In Sync with Natural Hearing

Arterial Stiffness: pathophysiology and clinical impact. Gérard M. LONDON Manhès Hospital Fleury-Mérogis/Paris, France

Central hemodynamics and prediction of cardiovascular events in patients with erectile dysfunction

Ambulatory arterial stiffness index as a predictor of cardiovascular events.

Cardiovascular Diseases Detecting via Pulse Analysis

Arterial function and longevity Focus on the aorta

QDR Series. Discovery and Explorer Advanced Health Assessment

Device Equivalence Evaluation Form

Preventing Early Vascular Ageing (EVA) and its hemodynamic changes

Biomechanics of Ergometric Stress Test: regional and local effects on elastic, transitional and muscular human arteries

The Definitive Dental 3D Printing Solution

Improving risk prediction focusing on intermediate endpoints. Arterial stiffness. Pr. Stéphane LAURENT, MD, PhD, FESC

Journal of Hypertension 2008, 26:

GSI TYMPSTAR PRO CLINICAL MIDDLE-EAR ANALYZER. Setting The Clinical Standard

Where BMI ends, seca the unique diagnostic and medical practices.

HDiag 37 - Vascular Assist 03 27/4/07 17:11 Page 1. Vascular Assessment Systems and Electronic Patient Record Software. DIAGNOSTIC Products Division

Device Equivalence Evaluation Form

AD226 Diagnostic Audiometer

Estimation of pressure pulse amplification between aorta and brachial artery using stepwise multiple regression models

Association between arterial stiffness and cardiovascular risk factors in a pediatric population

TECHNOCARE MEDISYSTEMS

Cardiocap/5. GE Healthcare. The compact, all-in-one, critical care monitor. Features. Available options

Niza Samsuddin 1, KG Rampal 2, Noor Hassim Ismail 3, Nur Zamzila Abdullah 4, Jamalludin Ab Rahman 1

Blood Pressure Response Under Chronic Antihypertensive Drug Therapy

A chronic increase in blood pressure is a major risk factor for cardiovascular disease, whereas reducing

Introduction. What s new in Genie 2? New Fitting features. Support for new hearing aids:

Device Equivalence Evaluation Form

HTA ET DIALYSE DR ALAIN GUERIN

Transcription:

Managing cardiovascular risk with SphygmoCor XCEL Central pulse pressure better predicts outcome than does brachial pressure Roman et al., Hypertension, 2007; 50:197-203 Carotid to femoral Pulse Wave Velocity >12m/s is an indicator of end organ damage European Society of Hypertension guidelines 2007

Carotid-femoral PWV shown to be predictive of CV risk Aortic PWV improves (Framingham) risk prediction when added to standard risk factors and may represent a valuable biomarker of cardiovascular disease risk Mitchell, Circulation. 2010;121:505-511 Aortic PWV is a strong independent predictor of all-cause and mainly cardiovascular mortality. Blacher, Circulation. 1999;99:2434-2439 For each 1-SD increment in apwv, the risk of an event increased by 16% to 20%. Willum Hansen, Circulation. 2006;113:664-670 Although PWV may be determined between other sites, such as the brachial-ankle, it is important to recognize that these do not provide the same information as cf-pwv not least because they include different segments of muscular arteries and often concern indirect pathways. Artery Society Guidelines for the validation of non invasive devices, 2010

Measuring carotid-femoral PWV with SphygmoCor XCEL SphygmoCor XCEL Gold standard carotid femoral PWV Simultaneous measurement with thigh cuff and high fidelity tonometer PWV measurements in 60 seconds Data equivalency with earlier SphygmoCor systems: average difference only 0.05m/s Correlation of r=0.91 1SD = 0.59m/s No undressing required Suitable for screening and epidemiological studies Risk stratification using healthy and normal reference ranges Aortic risk stratification by comparison to reference ranges Healthy population comparison - 4000 patients without traditional CV risk factors. European General population comparison - 11,092 patients without traditional CV risk factors, and stratified based on brachial blood pressure. Measurements below the line show a patient has cf-pwv that is lower than the average for their age.

Peripheral pressure and central aortic pressure are not the same Peripheral Pressure Central Pressure 2 patients similar cuff pressure of 144/90 Very different central pressure 136/91(red) and 122/90 (blue) Different cardiovascular risk based on Central systolic blood pressure and central pulse pressure Central pressure cannot be reliably inferred from peripheral pressure McEniery, et al. Hypertension 2008 Central pulse pressure defines a threshold for CV risk Patients with Central Pulse Pressure 50mmHg had a 20% CV event rate. Patients with Central Pulse Pressure < 50mmHg had a 10% CV event rate. The highest quartile of Brachial pulse pressure did not demonstrate greater CV risk. Roman, JACC, 2009 When central pulse pressure exceeds a threshold of 50mmHg, the risk of cardiovascular events in an individual doubles. Risk assessment using peripheral pressures does not show such a threshold.

Augmentation index indicator of arterial stiffness in younger patients. AIx AP Augmentation index increases until the age of about 50, in both males (solid line) and females (dashed line) Augmented pressure increases linearly with age in males and females. Central AIx might be a more sensitive marker of arterial aging and CV risk in younger individuals, <50 years Augmentation index predicts clinical events independently of peripheral pressures McEniery, JACC, 2005. Vlachopoulos, European Heart Journal, 2010 Both Augmentation index and Central Systolic pressure should be measured. Augmentation index indicator of arterial stiffness in renal patients London, Hypertension, 2001 After adjustment for all confounding factors, the risk ratio for each 10% increase in augmentation index was 1.48 for CV mortality. These results provide the first direct evidence that in ESRF patients increased effect of arterial wave reflections is an independent predictor of allcause and CV mortality. London, Hypertension. 2001;38:434-438 Framingham multiple variable risk score calculates high risk as 20% or more chance of event within 10 years. SphygmoCor Central Pulse pressure as a single variable predicts a 20% or more chance of event within 5 years.

Measuring Central Aortic Pressure with SphygmoCor XCEL Simple technique Place cuff on arm and press start. Measurement in 60 seconds. SphygmoCor brachial generalized transfer function. Easy to use, intuitive software Operator independent. Validation of SphygmoCor XCEL Central Aortic Pressure vs. SphygmoCor with tonometer waveform capture Central systolic blood pressure Average difference 0.5 mmhg ± 1.8 mmhg R value (correlation) r=.99 Central aortic pulse pressure Average difference 0.5 mmhg ± 1.5 mmhg R value (correlation) r=.99 Central augmentation index Average difference 1.8% ± 7% R value (correlation) r=.91 The estimation of aortic peak values and waveform features from the brachial cuff waveform is comparable to existing tonometricbased methods Butlin, ESH Poster 2012, publication in print

SphygmoCor XCEL Specifications Contact Information Options Operating Ambient Temperature Operating Relative Humidity External Power Supply (use only AtCor part number 1-00877) Physical Specifications Range SphygmoCor XCEL CBP SphygmoCor XCEL PWV SphygmoCor XCEL CBP and PWV +15 C to 40 C (59 F to 104 F) 15% to 95% non-condensing 100-240 VAC, 50-60Hz Enclosure Material Polycarbonate Weight 0.7 kg (1.5 lbs) Dimensions 9.9 (l) x 19 (w) x 17.2 (h) cm NIBP, PWV Sys: 50-260 mmhg Dia: 40-200 mmhg Heart rate 30-220 beats per minute Head Office AtCor Medical Pty Ltd West Ryde Corporate Centre Suite 11, 1059-1063 Victoria Rd. West Ryde NSW 2114 Sydney, Australia Telephone: + (61) 2 9874 8761 Facsimile: + (61) 2 9874 9022 Email:inquiry@atcormedical.com USA Office AtCor Medical Inc One Pierce Place, Suite 225-West Itasca, IL, 60143 USA Telephone: + (1) 630 228 8871 Facsimile: + (1) 630 228 8872 Email: atcorusa@atcormedical.com Non invasive BP measurements provided by Suntech Advantage Mini validated to BHS and IEC standards Minimum computer Specifications European Office Email: contact.europe@atcormedical.com Web: www.atcormedical.com Type Processor Nominal Speed Memory Hard Disk Accessories Printer Drivers Communications Minimum Display Resolution Operating Systems IBM Compatible PC Intel or compatible, 32 bits 2GHz minimum 1GB RAM minimum 2GB for Installation 10GB for database DVD drive Standard USB port 1024 x 768 pixels Windows XP Professional + SP3, or Windows 7 Professional Managing risk with SphygmoCor XCEL DCN 101352, Revision 2.

AtCor Medical